Back to School: How biopharma can reboot drug development. Access exclusive analysis here

ACTOplus Metpioglitazone/metformin regulatory update

CHMP recommended removing a contraindication from the label of Competact pioglitazone/metformin warning against concurrent administration

Read the full 157 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE